Why progressive barns are re-thinking joint injections
Lameness and osteoarthritis remain the leading causes of lost training days in performance horses. For decades, intra-articular corticosteroids and hyaluronic acid were the default tools for keeping show jumpers, barrel racers, and pleasure horses comfortable. Today, growing concern about steroid-related cartilage damage and medication rules at sanctioned competitions has owners and veterinarians looking for alternatives that are both effective and competition-safe. One of the most talked-about options is Pro-Stride® Autologous Protein Solution (APS)—often shortened to “Pro-Stride Equine.”
What exactly is Pro-Stride APS?
Pro-Stride APS is a stall-side, regenerative therapy that uses the horse’s own blood to create a concentrated fluid rich in anti-inflammatory proteins, growth factors, and platelets. The treatment is designed to be injected into an affected joint, where it reduces inflammation and stimulates healing rather than merely masking pain. According to Zoetis, the manufacturer, the entire procedure—from blood draw to joint injection—can be completed in under 20 minutes, eliminating the need for an off-site lab.
The two-step stall-side process
- Blood collection and centrifugation. A small volume of whole blood is drawn from the jugular vein. Using a proprietary dual-chamber canister and portable centrifuge, the practitioner separates red cells from platelets, white cells, and plasma.
- Concentration and injection. The anti-inflammatory-rich plasma is further filtered inside the same sterile device, producing about 3–5 mL of APS. This solution is drawn into a syringe and injected aseptically into the target joint.
Key biological components inside the syringe
While the term “platelet-rich plasma” (PRP) often comes up in conversation, Pro-Stride APS differs from basic PRP in several ways:
Interleukin-1 Receptor Antagonist Protein (IRAP)
IRAP binds to the same cellular receptors as the pro-inflammatory cytokine interleukin-1 (IL-1) but does not activate them. By blocking IL-1, IRAP helps slow cartilage degradation. This mechanism is central to the long-duration pain relief—up to 52 weeks—reported in multiple field studies and cited by Sporthorse Veterinary Services.
Platelets and growth factors
Platelets release transforming growth factor-β, platelet-derived growth factor, and other cytokines that recruit reparative cells to damaged cartilage and sub-chondral bone. The resulting environment favors tissue regeneration rather than scar formation.
White blood cells
Controlled numbers of neutrophils and monocytes in APS aid in clearing cellular debris and orchestrating the early inflammatory cascade necessary for tissue remodeling, while the high IRAP concentration tempers destructive inflammation.
How Pro-Stride compares with traditional joint therapies
Corticosteroids provide rapid pain relief but can accelerate cartilage thinning when administered repeatedly. Hyaluronic acid improves lubrication yet offers limited anti-inflammatory action on its own. By contrast, Pro-Stride APS delivers anti-inflammatory, anabolic, and lubricative effects in a single autologous formulation—without introducing a foreign drug that would trigger withdrawal times. Performance Equine Veterinary Services states that the treatment can be repeated as needed without the cumulative cartilage risk associated with steroids, making it an attractive choice for horses with chronic issues.
Real-world observations from the barn aisle
Because Pro-Stride is ambulatory-friendly, many veterinarians perform the therapy between classes at a show or during routine wellness visits. Horses typically stand quietly under light sedation—often the same level used for dental floats—and are back in their stalls within half an hour.
At a Midwestern hunter-jumper barn, a 12-year-old Warmblood with chronic hock arthritis had plateaued even with regular corticosteroid injections and a daily joint supplement. After a single Pro-Stride treatment, the gelding showed a one-grade lameness reduction within two weeks and maintained that improvement through the entire show season, eliminating the need for mid-season steroid top-ups.
In an eventing program, a 9-year-old Thoroughbred mare received Pro-Stride in both front fetlocks. The barn manager noted that post-cross-country ice time was reduced from 30 minutes to 15 minutes because the joints were “simply not blowing up” the way they once had—saving labor and consumables such as ice boots.
What peer-reviewed and clinical data reveal
In a prospective, randomized study presented at the American Association of Equine Practitioners convention, horses treated with Pro-Stride exhibited statistically significant improvement in lameness scores for up to 52 weeks compared with saline controls. Field reports submitted to Zoetis detail over 35,000 clinical doses with adverse events limited primarily to transient post-injection flare—comparable to other intra-articular procedures. No long-term deleterious effects on cartilage have been documented to date.
Safety profile and medication regulations
Because APS is created from the horse’s own blood, the risk of an immune reaction is negligible. Infection risk mirrors that of any joint injection and is mitigated by strict sterile technique. Most governing bodies, including the United States Equestrian Federation, currently classify Pro-Stride as a non-restricted therapy, but owners should confirm regulations prior to competition.
When is the right time to consider Pro-Stride?
Veterinarians often recommend the therapy in three scenarios:
- A young sport horse with early cartilage changes where owners wish to avoid steroids.
- A middle-aged horse that no longer responds to traditional injections.
- A geriatric companion requiring long-term relief without systemic medication.
Frequently asked questions from owners
How soon can my horse return to work?
Light hand-walking is generally permitted the day after treatment, with return to full work in 3–5 days unless concurrent procedures (for example, arthroscopy) dictate otherwise.
Does my horse need multiple injections?
Many horses experience a year of relief from a single joint dose, but highly athletic horses or those with severe degeneration might benefit from re-treatment at six-month intervals.
Is Pro-Stride the same as PRP?
No. PRP is platelet-rich plasma focused on growth factors. Pro-Stride APS adds a powerful concentration of IRAP, giving it a stronger anti-inflammatory profile.
Watch the process in action
The short video below, produced by Zoetis, walks through each preparation step so owners know what to expect on treatment day.
Final thoughts: a forward-looking tool for soundness
As the quest for safe, durable joint therapies continues, Pro-Stride Equine stands out for its combination of biological sophistication and real-world practicality. By harnessing proteins and platelets the horse already possesses, it offers a drug-free path to pain relief and cartilage preservation. From weekend trail mounts to six-figure show horses, the therapy delivers a compelling blend of scientific rigor and tangible barn-aisle results.
Veterinarians will continue to tailor joint care to individual needs, sometimes combining Pro-Stride with modalities such as shockwave therapy, controlled exercise, and topical liniment. Yet the core promise remains the same: longer-lasting comfort achieved through the horse’s own healing potential. For owners committed to proactive, evidence-based care, Pro-Stride APS is rapidly becoming an indispensable part of the lameness toolbox.
For in-depth technical information, consult the product overview at Zoetis, or review clinical case notes shared by the teams at Sporthorse Veterinary Services and Performance Equine Vets. Armed with those insights—and a trusted veterinary partnership—owners can make informed decisions that keep their horses moving freely for seasons to come.